Last reviewed · How we verify

Metformin plus clomiphene citrate — Competitive Intelligence Brief

Metformin plus clomiphene citrate (Metformin plus clomiphene citrate) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Combination therapy: biguanide + selective estrogen receptor modulator (SERM). Area: Reproductive Endocrinology / Fertility.

marketed Combination therapy: biguanide + selective estrogen receptor modulator (SERM) Insulin signaling pathway (metformin); estrogen receptor (clomiphene citrate) Reproductive Endocrinology / Fertility Small molecule Live · refreshed every 30 min

Target snapshot

Metformin plus clomiphene citrate (Metformin plus clomiphene citrate) — University Magna Graecia. Metformin reduces hepatic glucose production and improves insulin sensitivity, while clomiphene citrate acts as a selective estrogen receptor modulator to stimulate ovulation and restore reproductive function.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Metformin plus clomiphene citrate TARGET Metformin plus clomiphene citrate University Magna Graecia marketed Combination therapy: biguanide + selective estrogen receptor modulator (SERM) Insulin signaling pathway (metformin); estrogen receptor (clomiphene citrate)
Metformin + Clomiphene Metformin + Clomiphene University of Auckland, New Zealand marketed Combination therapy: biguanide + selective estrogen receptor modulator (SERM) Metformin: AMP-activated protein kinase (AMPK); Clomiphene: estrogen receptor (ER)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Combination therapy: biguanide + selective estrogen receptor modulator (SERM) class)

  1. University Magna Graecia · 1 drug in this class
  2. University of Auckland, New Zealand · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Metformin plus clomiphene citrate — Competitive Intelligence Brief. https://druglandscape.com/ci/metformin-plus-clomiphene-citrate. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: